BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16607774)

  • 1. [Gastroesophageal reflux involvement in ENT disorders].
    Drug VL; Cobzeanu D; Papaghiuc C; Ciochină P; Gogălniceanu P; Bugioianoun C; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):220-2. PubMed ID: 16607774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
    Ahmed TF; Khandwala F; Abelson TI; Hicks DM; Richter JE; Milstein C; Vaezi MF
    Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid reflux management: ENT perspective.
    Ahmad I; Batch AJ
    J Laryngol Otol; 2004 Jan; 118(1):25-30. PubMed ID: 14979968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the art: extraesophageal manifestations of gastroesophageal reflux disease.
    Katz PO
    Rev Gastroenterol Disord; 2005; 5(3):126-34. PubMed ID: 16127347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ENT manifestations of gastroesophageal reflux disease (GERD)].
    Watanabe Y
    Nihon Rinsho; 2004 Aug; 62(8):1533-6. PubMed ID: 15344546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
    Issing WJ; Tauber S; Folwaczny C; Reichel O
    Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders.
    Monini S; Di Stadio A; Vestri A; Barbara M
    Acta Otolaryngol; 2006 Aug; 126(8):866-71. PubMed ID: 16846931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
    Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
    Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of gastroesophageal reflux and chronic laryngitis].
    Jaspersen D; Weber R; Hammar CH; Draf W
    Leber Magen Darm; 1995 Sep; 25(5):218-9. PubMed ID: 7500809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of long-term outcome of patients with reflux-related ear, nose, and throat symptoms.
    Poelmans J; Feenstra L; Tack J
    Dig Dis Sci; 2006 Feb; 51(2):282-8. PubMed ID: 16534670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngeal disorders in patients with gastroesophageal reflux disease.
    Farrokhi F; Vaezi MF
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):181-7. PubMed ID: 17557046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Manifestations of gastroesophageal reflux in the otorhinolaryngology tract].
    Issing WJ; Gross M; Tauber S
    Laryngorhinootologie; 2001 Aug; 80(8):464-9. PubMed ID: 11552426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra-esophageal disorders in gastroesophageal reflux disease.
    Jaspersen D
    Dig Dis; 2004; 22(2):115-9. PubMed ID: 15383751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy Insight: gastroesophageal reflux disease and laryngopharyngeal reflux.
    Vaezi MF
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):595-603. PubMed ID: 16327839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraesophageal manifestations of gastroesophageal reflux disease: real or imagined?
    Moore JM; Vaezi MF
    Curr Opin Gastroenterol; 2010 Jul; 26(4):389-94. PubMed ID: 20473157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic strategies for laryngeal manifestations of gastroesophageal reflux disease.
    Yuksel ES; Vaezi MF
    J Clin Gastroenterol; 2013 Mar; 47(3):195-204. PubMed ID: 23340061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
    Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
    Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reflux-associated diseases of the otorhinolaryngology tract].
    Rosanowski F; Rabenstein T; Hahn EG; Eysholdt U
    Laryngorhinootologie; 2001 Aug; 80(8):487-96. PubMed ID: 11552431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.